tirzepatide sleep apnea trial In the two SURMOUNT-OSA trials, researchers assessed the efficacy and safety of for the treatment of adults with obstructive and obesity. Full results of both trials and Plain Language Tirzepatide: A Dual Solution for

Preclinical studies document stimulation of collagen and glycosaminoglycan synthesis, upregulation of antioxidant enzymes including superoxide dismutase, and activation of matrix metalloproteinase pathways involved in tissue remodeling and scar resolution

Patients should speak with a qualified medical provider before considering peptide therapy and should avoid unverified products or self-directed dosing protocols

Other limitations of these trials include the exclusion of sleepy patients with OSA, evaluation of composite rather than individual cardiovascular outcomes, and low PAP adherence [29]

This can help prevent chronically high insulin levels, which are associated with insulin resistance, weight gain, and various metabolic disorders